Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer

Dana M Chase Division of Gynecologic Oncology, Creighton University School of Medicine at St Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. [email protected]; Division of Gynecologic Oncology, Creighton University School of Medicine at St Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. [email protected]

Lari B Wenzel University of California, Irvine, CA 92697, USA; University of California, Irvine, CA 92697, USA

Bradley J Monk Division of Gynecologic Oncology, Creighton University School of Medicine at St Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. [email protected]; Division of Gynecologic Oncology, Creighton University School of Medicine at St Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. [email protected]

References

Brundage M, Gropp M, Mefti F et al. Health-related quality of life in recurrent platinum-sensitive ovarian cancer – results from the CALYPSO trial. Ann. Oncol. doi:10.1093/annonc/mdr583 (2012) (Epub ahead of print).
PubMedGoogle Scholar
Pujade-Lauraine E, Wagner U, Aavall-Lundqvist E et al. Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse. J. Clin. Oncol. 28(20), 3323–3329 (2010).
PubMed Web of Science ®Google Scholar
Marth C, Alexandre J, Hanker LC et al. Pegylated liposomal doxorubicin and carboplatin (C-PLD) versus paclitaxel and carboplatin (C-P) in platinum-sensitive ovarian cancer (OC) patients (pts): treatment at recurrence and overall survival final analysis from CALPYSO Phase III GCIG trial. J. Clin. Oncol. 29(Suppl.), (2011) (Abstract 5052).
PubMedGoogle Scholar
von Gruenigen VE, Huang HQ, Gil KM, Frasure HE, Armstrong DK, Wenzel LB. The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study. Gynecol. Oncol. 124(3), 379–382 (2012).
PubMed Web of Science ®Google Scholar
Grover S, Hill-Kayser CE, Vachani C, Hampshire MK, DiLullo GA, Metz JM. Patient reported late effects of gynecological cancer treatment. Gynecol. Oncol. 124(3), 399–403 (2012).
PubMed Web of Science ®Google Scholar
Chase DM, Wenzel L. Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Rev. Pharmacoecon. Outcomes Res. 11(4), 421–431 (2011).
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date